Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078–1094 (2021).
Google Scholar
Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840–854 (2022).
Google Scholar
Witten, J., Hu, Y., Langer, R. & Anderson, D. G. Recent advances in nanoparticulate RNA delivery systems. Proc. Natl Acad. Sci. USA 121, e2307798120 (2024).
Google Scholar
Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).
Google Scholar
Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021).
Google Scholar
Gillmore, J. D. et al. CRISPR–Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493–502 (2021).
Google Scholar
Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. 39, 949–957 (2021).
Google Scholar
Heymans, S. & Cooper, L. T. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat. Rev. Cardiol. 19, 75–77 (2022).
Google Scholar
vander Straeten, A. et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat. Biotechnol. 42, 510–517 (2024).
Google Scholar
Muramatsu, H. et al. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol. Ther. 30, 1941–1951 (2022).
Google Scholar
Loughrey, D. & Dahlman, J. E. Non-liver mRNA delivery. Acc. Chem. Res. 55, 13–23 (2022).
Google Scholar
Hodges, C. A. & Conlon, R. A. Delivering on the promise of gene editing for cystic fibrosis. Genes Dis. 6, 97–108 (2018).
Google Scholar
Ensinck, M., Mottais, A., Detry, C., Leal, T. & Carlon, M. S. On the corner of models and cure: gene editing in cystic fibrosis. Front. Pharmacol. 12, 662110 (2021).
Google Scholar
Choi, S. H. & Engelhardt, J. F. Gene therapy for cystic fibrosis: lessons learned and paths forward. Mol. Ther. 29, 428–430 (2021).
Google Scholar
Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174–1185 (2019).
Google Scholar
Ruigrok, M. J. R., Frijlink, H. W., Melgert, B. N., Olinga, P. & Hinrichs, W. L. J. Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Mol. Ther. Methods Clin. Dev. 20, 483–496 (2021).
Google Scholar
Bai, X. et al. Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge. Sci. Adv. 8, eabn7162 (2022).
Google Scholar
Zhang, R. et al. Inhaled mRNA nanoformulation with biogenic ribosomal protein reverses established pulmonary fibrosis in a bleomycin-induced murine model. Adv. Mater. 34, e2107506 (2022).
Google Scholar
Guan, S., Darmstädter, M., Xu, C. & Rosenecker, J. In vitro investigations on optimizing and nebulization of IVT-mRNA formulations for potential pulmonary-based alpha-1-antitrypsin deficiency treatment. Pharmaceutics 13, 1281 (2021).
Google Scholar
Wu, D.-D. et al. The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach. Pharmacol. Ther. 182, 1–14 (2018).
Google Scholar
Woo, C. J. et al. Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia. Pulm. Pharmacol. Ther. 75, 102134 (2022).
Google Scholar
da Silva, A. L. et al. Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma. Sci. Adv. 6, eaay7973 (2020).
Google Scholar
Zeyer, F. et al. mRNA-mediated gene supplementation of Toll-like receptors as treatment strategy for asthma in vivo. PLoS ONE 11, e0154001 (2016).
Google Scholar
Sabnis, S. et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol. Ther. 26, 1509–1519 (2018).
Google Scholar
Hashiba, K. et al. Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci. 3, 2370001 (2023).
Google Scholar
Lam, K. et al. Unsaturated, trialkyl ionizable lipids are versatile LNP components for therapeutic and vaccine applications. Adv. Mater. 35, 2209624 (2023).
Google Scholar
Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).
Google Scholar
Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002–1008 (2024).
Google Scholar
Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688–702.e13 (2020).
Google Scholar
Yang, K. et al. Analyzing learned molecular representations for property prediction. J. Chem. Inf. Model. 59, 3370–3388 (2019).
Google Scholar
Soleimany, A. P. et al. Evidential deep learning for guided molecular property prediction and discovery. ACS Cent. Sci. 7, 1356–1367 (2021).
Google Scholar
Reker, D. et al. Computationally guided high-throughput design of self-assembling drug nanoparticles. Nat. Nanotechnol. 16, 725–733 (2021).
Google Scholar
Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342–1350 (2023).
Google Scholar
Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177–185 (2024).
Google Scholar
Rhym, L. H., Manan, R. S., Koller, A., Stephanie, G. & Anderson, D. G. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery. Nat. Biomed. Eng. 7, 901–910 (2023).
Google Scholar
Ryan, K. A. et al. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity. Nat. Commun. 12, 81 (2021).
Google Scholar
Rosen, B. H. et al. Animal and model systems for studying cystic fibrosis. J. Cyst. Fibros. 17, S28–S34 (2018).
Google Scholar
Yuan, F. et al. Transgenic ferret models define pulmonary ionocyte diversity and function. Nature 621, 857–867 (2023).
Google Scholar
Rotolo, L. et al. Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung. Nat. Mater. 22, 369–379 (2023).
Google Scholar
Boucher, R. C. Muco-obstructive lung diseases. N. Engl. J. Med. 380, 1941–1953 (2019).
Google Scholar
Li, B. et al. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-023-01082-6 (2023).
Jiang, A. Y. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364–375 (2024).
Google Scholar
Miller, J. B. et al. Non-viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA. Angew. Chem. Int. Ed. 56, 1059–1063 (2017).
Google Scholar
Zhou, K. et al. Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model. Proc. Natl Acad. Sci. USA 113, 520–525 (2016).
Google Scholar
Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing. Nat. Mater. 20, 701–710 (2021).
Google Scholar
Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410–1415 (2023).
Google Scholar
Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561–569 (2008).
Google Scholar
Lee, S. M. et al. A systematic study of unsaturation in lipid nanoparticles leads to improved mRNA transfection in vivo. Angew. Chem. 133, 5912–5917 (2021).
Google Scholar
Li, L. et al. A biomimetic lipid library for gene delivery through thiol-yne click chemistry. Biomaterials 33, 8160–8166 (2012).
Google Scholar
Heid, E. et al. Chemprop: a machine learning package for chemical property prediction. J. Chem. Inf. Model. 64, 9–17 (2024).
Google Scholar
Wu, Z. et al. MoleculeNet: a benchmark for molecular machine learning. Chem. Sci. 9, 513–530 (2018).
Google Scholar
He, Z. et al. A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery. Angew. Chem. Int. Ed. 62, e202310401 (2023).
Google Scholar
Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300–7306 (2015).
Google Scholar
Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638–646 (2013).
Google Scholar
Carrasco, M. J. et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun. Biol. 4, 956 (2021).
Google Scholar
Fischer, A. J. et al. Mucus strands from submucosal glands initiate mucociliary transport of large particles. JCI Insight 4, e124863 (2019).
Google Scholar
Ostedgaard, L. S. et al. Lack of airway submucosal glands impairs respiratory host defenses. eLife 9, e59653 (2020).
Google Scholar
Tata, P. R. & Rajagopal, J. Plasticity in the lung: making and breaking cell identity. Development 144, 755–766 (2017).
Google Scholar
Plasschaert, L. W. et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature 560, 377–381 (2018).
Google Scholar
Shah, V. S., Chivukula, R. R., Lin, B., Waghray, A. & Rajagopal, J. Cystic fibrosis and the cells of the airway epithelium: what are ionocytes and what do they do? Annu. Rev. Pathol. Mech. Dis. 17, 23–46 (2022).
Google Scholar
Bajusz, D., Rácz, A. & Héberger, K. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J. Cheminform. 7, 20 (2015).
Google Scholar
Miao, L. et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat. Commun. 11, 2424 (2020).
Google Scholar
Witten, J. & Collins, E. LNP ML. GitHub https://github.com/jswitten/LNP_ML (2024).
Guo, Z. et al. Diffusion models in bioinformatics and computational biology. Nat. Rev. Bioeng. 2, 136–154 (2024).
Google Scholar
Reverberi, C. et al. Experimental evidence of effective human–AI collaboration in medical decision-making. Sci. Rep. 12, 14952 (2022).
Google Scholar
Xu, Y., Golubovic, A., Xu, S., Pan, A. & Li, B. Rational design and combinatorial chemistry of ionizable lipids for RNA delivery. J. Mater. Chem. B 11, 6527–6539 (2023).
Google Scholar
Du, S. et al. Cholesterol-amino-phosphate (CAP) derived lipid nanoparticles for delivery of self-amplifying RNA and restoration of spermatogenesis in infertile mice. Adv. Sci. 10, 2300188 (2023).
Google Scholar
Andries, O. et al. Comparison of the gene transfer efficiency of mRNA/GL67 and pDNA/GL67 complexes in respiratory cells. Mol. Pharm. 9, 2136–2145 (2012).
Google Scholar
Hou, X. et al. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat. Nanotechnol. 15, 41–46 (2020).
Google Scholar
Oyama, R. et al. An ionizable lipid material with a vitamin E scaffold as an mRNA vaccine platform for efficient cytotoxic T cell responses. ACS Nano 17, 18758–18774 (2023).
Google Scholar
Goldman, R. L. et al. Understanding structure activity relationships of good HEPES lipids for lipid nanoparticle mRNA vaccine applications. Biomaterials 301, 122243 (2023).
Google Scholar
Yan, Z., McCray, P. B. Jr & Engelhardt, J. F. Advances in gene therapy for cystic fibrosis lung disease. Hum. Mol. Genet. 28, R88–R94 (2019).
Google Scholar
Lee, J.-A. et al. Gene therapy for cystic fibrosis: new tools for precision medicine. J. Transl. Med. 19, 452 (2021).
Google Scholar
Boucher, R. C. Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103, 441–445 (1999).
Google Scholar
Ulrich, M. et al. Alveolar inflammation in cystic fibrosis. J. Cyst. Fibros. 9, 217–227 (2010).
Google Scholar
Lin, C.-R., Bahmed, K. & Kosmider, B. Impaired alveolar re-epithelialization in pulmonary emphysema. Cells 11, 2055 (2022).
Google Scholar
Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948–6951 (2012).
Google Scholar
Ferguson, L. T. et al. Mechanisms by which liposomes improve inhaled drug delivery for alveolar diseases. Adv. NanoBiomed Res. 3, 2200106 (2023).
Google Scholar
Yu, M. et al. Highly efficient transgenesis in ferrets using CRISPR/Cas9-mediated homology-independent insertion at the ROSA26 locus. Sci. Rep. 9, 1971 (2019).
Google Scholar
Tang, Y. et al. Repeat dosing of AAV2.5T to ferret lungs elicits an antibody response that diminishes transduction in an age-dependent manner. Mol. Ther. Methods Clin. Dev. 19, 186–200 (2020).
Google Scholar
Tang, Y. et al. Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs. Mol. Ther. Methods Clin. Dev. 29, 70–80 (2023).
Google Scholar
